Compare Stocks: VTL, PALI, ACOG, and ANTX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACOG Alpha Cognition	$8.30 -3.0%	$8.76	$4.50 ▼ $10.14	$180.77M	2.32	82,157 shs	15,698 shs
ANTX Anthem	$4.39 -1.1%	$4.64	$1.00 ▼ $7.19	$166.56M	-0.93	587,219 shs	38,763 shs
PALI Palisade Bio	$1.09 -4.8%	$1.50	$1.08 ▼ $2.86	$194.52M	1.61	3.58 million shs	522,828 shs
VTL Vital Therapies	$1.19	$8.88	$0.15 ▼ $9.75	$50.42M	3.51	21.62 million shs	1.31 million shs

Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACOG Alpha Cognition	-0.70%	+5.03%	-2.73%	-3.17%	+39.87%
ANTX Anthem	-0.45%	+12.41%	+23.33%	-25.88%	+274.68%
PALI Palisade Bio	-2.56%	-1.72%	-22.18%	-46.73%	-44.12%
VTL Vital Therapies	0.00%	0.00%	0.00%	0.00%	+52.58%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACOG Alpha Cognition	$8.30 -3.0%	$8.76	$4.50 ▼ $10.14	$180.77M	2.32	82,157 shs	15,698 shs
ANTX Anthem	$4.39 -1.1%	$4.64	$1.00 ▼ $7.19	$166.56M	-0.93	587,219 shs	38,763 shs
PALI Palisade Bio	$1.09 -4.8%	$1.50	$1.08 ▼ $2.86	$194.52M	1.61	3.58 million shs	522,828 shs
VTL Vital Therapies	$1.19	$8.88	$0.15 ▼ $9.75	$50.42M	3.51	21.62 million shs	1.31 million shs

Don't Wait for the OpenAI IPO

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACOG Alpha Cognition	-0.70%	+5.03%	-2.73%	-3.17%	+39.87%
ANTX Anthem	-0.45%	+12.41%	+23.33%	-25.88%	+274.68%
PALI Palisade Bio	-2.56%	-1.72%	-22.18%	-46.73%	-44.12%
VTL Vital Therapies	0.00%	0.00%	0.00%	0.00%	+52.58%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACOG Alpha Cognition	3.00	Buy	$18.20	119.28% Upside
ANTX Anthem	2.33	Hold	$9.00	105.01% Upside
PALI Palisade Bio	3.00	Buy	$9.00	729.49% Upside
VTL Vital Therapies	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest VTL, PALI, ACOG, and ANTX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/12/2026	ACOG Alpha Cognition	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target	Outperform	$21.00
11/11/2026	PALI Palisade Bio	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$5.00
10/21/2026	PALI Palisade Bio	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Outperform
10/13/2026	PALI Palisade Bio	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$7.00
10/12/2026	PALI Palisade Bio	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (E+)
10/8/2026	PALI Palisade Bio	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Outperform	$6.00
10/8/2026	PALI Palisade Bio	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Outperform	$6.00
10/2/2026	ANTX Anthem	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/23/2026	PALI Palisade Bio	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$7.00
8/20/2026	ACOG Alpha Cognition	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Initiated Coverage	Buy	$21.00
8/17/2026	ACOG Alpha Cognition	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$18.00 ➝ $20.00

(Data available from 11/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACOG Alpha Cognition	$10.22M	17.69	N/A	N/A	$2.88 per share	2.88
ANTX Anthem	N/A	N/A	N/A	N/A	$1.99 per share	N/A
PALI Palisade Bio	$250K	778.08	N/A	N/A	$0.63 per share	1.72
VTL Vital Therapies	N/A	N/A	N/A	N/A	$0.29 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACOG Alpha Cognition	-$20.67M	-$1.10	N/A	N/A	N/A	-147.26%	-50.90%	-41.23%	N/A
ANTX Anthem	-$35.17M	-$0.93	N/A	N/A	N/A	N/A	-48.74%	-44.56%	N/A
PALI Palisade Bio	-$16.78M	-$0.48	N/A	N/A	N/A	N/A	-35.60%	-34.04%	N/A
VTL Vital Therapies	-$41.47M	N/A	N/A	N/A	N/A	N/A	-235.33%	-182.35%	N/A

Latest VTL, PALI, ACOG, and ANTX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/11/2026	Q3 2026	ACOG Alpha Cognition	-$0.3350	-$0.35	-$0.0150	-$0.35	$7.04 million	$7.78 million
11/10/2026	Q3 2026	PALI Palisade Bio	-$0.0610	-$0.07	-$0.0090	-$0.07	N/A	N/A
11/9/2026	Q3 2026	ANTX Anthem	N/A	-$0.17	N/A	-$0.17	N/A	N/A
8/13/2026	Q2 2026	ACOG Alpha Cognition	-$0.3921	-$0.40	-$0.0079	-$0.40	$4.38 million	$6.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACOG Alpha Cognition	N/A	N/A	N/A	N/A	N/A
ANTX Anthem	N/A	N/A	N/A	N/A	N/A
PALI Palisade Bio	N/A	N/A	N/A	N/A	N/A
VTL Vital Therapies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACOG Alpha Cognition	N/A	9.03	8.04
ANTX Anthem	N/A	10.48	14.32
PALI Palisade Bio	N/A	20.16	24.26
VTL Vital Therapies	N/A	6.97	6.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ACOG Alpha Cognition	N/A
ANTX Anthem	90.47%
PALI Palisade Bio	11.79%
VTL Vital Therapies	15.52%

Insider Ownership

Company	Insider Ownership
ACOG Alpha Cognition	8.60%
ANTX Anthem	22.61%
PALI Palisade Bio	0.07%
VTL Vital Therapies	33.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ACOG Alpha Cognition	71	21.78 million	19.91 million	Optionable
ANTX Anthem	N/A	37.94 million	29.37 million	Optionable
PALI Palisade Bio	14	179.28 million	174.15 million	Not Optionable
VTL Vital Therapies	10	42.37 million	N/A	Not Optionable

VTL, PALI, ACOG, and ANTX Headlines

Recent News About These Companies

18,000 vulnerable children could lose ‘vital’ therapy as adoption fund faces axe

March 31, 2025 | msn.com

Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing

November 11, 2024 | benzinga.com

Respiratory Therapy program continues to thrive at Vermont State University

November 5, 2024 | vermontbiz.comV

Respiratory Therapy program continues to thrive at Vermont State University

November 5, 2024 | vermontbiz.comV

Lighthouse Center for Vital Living celebrates new building

October 30, 2024 | duluthnewstribune.comD

Alternative Wellness Therapies in the Tahoe Basin

October 11, 2024 | tahoedailytribune.comT

Addressing Trauma: A Vital Component in Behavioral Health

October 3, 2024 | ajmc.comA

Vital Care Receives Strategic Investment From Berkshire Partners, Leonard Green & Partners, and Linden Capital Partners

August 1, 2024 | tmcnet.com

Veterans lobbied for psychedelic therapy, but it may not be enough to save MDMA drug application

July 26, 2024 | msn.com

Ending Therapy

May 24, 2024 | psychologytoday.comP

Medication and Therapy

May 23, 2024 | psychologytoday.comP

Vardhman Textiles Ltd.

May 22, 2024 | wsj.com

North Carolina tells nature-based therapy program to stop admissions during probe of boy’s death

February 13, 2024 | msn.com

Is IV therapy safe? What to know about the growing industry and its expansion in Houston

January 28, 2024 | houstonchronicle.comH

Executive Summary: New York State Fiscal Year 2024-2025 Budget

January 26, 2024 | jdsupra.com

5 for Good: Therapeutic riding program helps build strength, social skills

December 7, 2023 | msn.com

Why High-Quality Raw Materials Are Vital | Producing Therapeutic Cardiomyocytes from iPSC Stem Cells

November 30, 2023 | fiercebiotech.comF

Is Online Therapy Effective?

November 28, 2023 | laweekly.comL

Understanding T lymphocytes inner workings to harness therapeutic potential

November 13, 2023 | openaccessgovernment.orgO

Baxter’s Proposed Kidney Spinoff Business Gets a Name

November 1, 2023 | mddionline.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

VTL, PALI, ACOG, and ANTX Company Descriptions

Alpha Cognition NASDAQ:ACOG

$8.30 -0.26 (-3.04%)

As of 11:46 AM Eastern

Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

Anthem NASDAQ:ANTX

$4.39 -0.05 (-1.13%)

As of 11:54 AM Eastern

Anthem, Inc., through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products. The company also provides a range of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs, and other administrative services. In addition, it offers an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits, radiology benefit management, and analytics-driven personal health care guidance; and Medicare administrative services. Further, the company provides services to the federal government in connection with the Federal Employee Program; and operates as a licensee of the Blue Cross and Blue Shield Association. As of December 31, 2017, it served 40.2 million medical members through its affiliated health plans. The company was formerly known as WellPoint, Inc. and changed its name to Anthem, Inc. in December 2014. Anthem, Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Palisade Bio NASDAQ:PALI

$1.08 -0.06 (-4.82%)

As of 11:55 AM Eastern

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor, currently under pre-clinical development as a therapeutic for patients living with inflammatory bowel diseases, including ulcerative colitis and Crohn's disease (CD), as well as develops PALI-1908, an oral, selective PDE4 inhibitor prodrug that is locally bioactivated in the terminal ileum of CD patients, currently in the research stage. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California; a co-development and distribution agreement with Newsoara Biopharma Co., Ltd; and a transformative strategic collaboration with Strand Life Sciences for advancing precision medicine for ulcerative colitis therapy. The company is based in Carlsbad, California.

Vital Therapies NASDAQ:VTL

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VTL, PALI, ACOG, and ANTX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VTL, PALI, ACOG, and ANTX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VTL, PALI, ACOG, and ANTX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VTL, PALI, ACOG, and ANTX Company Descriptions

Alpha Cognition NASDAQ:ACOG

Anthem NASDAQ:ANTX

Palisade Bio NASDAQ:PALI

Vital Therapies NASDAQ:VTL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest VTL, PALI, ACOG, and ANTX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest VTL, PALI, ACOG, and ANTX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

VTL, PALI, ACOG, and ANTX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

VTL, PALI, ACOG, and ANTX Company Descriptions

Alpha Cognition NASDAQ:ACOG

Anthem NASDAQ:ANTX

Palisade Bio NASDAQ:PALI

Vital Therapies NASDAQ:VTL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools